{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T18:45:51Z","timestamp":1782499551430,"version":"3.54.5"},"reference-count":60,"publisher":"Public Library of Science (PLoS)","issue":"6","license":[{"start":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T00:00:00Z","timestamp":1782432000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS One"],"abstract":"<jats:sec id=\"sec001\">\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Tuberculosis (TB) remains a major public health challenge globally, with drug-resistant strains, particularly rifampicin-resistant\n                      <jats:italic>Mycobacterium tuberculosis<\/jats:italic>\n                      (RR-MTB), which poses serious challenges for treatment and control. Rifampicin resistance is widely recognized as a key surrogate marker for multidrug-resistant MTB and is associated with poor treatment outcomes and increased transmission risk. Ethiopia is among the high-TB-burden countries, and the Amhara National Regional State continues to report significant tuberculosis morbidity and mortality.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec002\">\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>\n                      To assess the prevalence, rifampicin resistance patterns, and associated factors of\n                      <jats:italic>M. tuberculosis<\/jats:italic>\n                      among pulmonary tuberculosis-suspected patients at the Amhara National Regional State Comprehensive Specialized Hospitals, Northwest Ethiopia.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec003\">\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      A multicenter prospective cross-sectional study was conducted among pulmonary tuberculosis-suspected patients attending the Comprehensive Specialized Hospitals from April 2023, to May 2025. Socio-demographic and associated factors data were collected using semi-structured questionnaires. Sputum was collected and tested using GeneXpert MTB\/RIF assay to detect\n                      <jats:italic>M. tuberculosis<\/jats:italic>\n                      and rifampicin resistance. Data were entered into SPSS version 28 for analysis. Binary logistic regression was applied to assess the relationship between predictors and the prevalence of\n                      <jats:italic>M. tuberculosis,<\/jats:italic>\n                      and rifampicin resistance. Variables with a\n                      <jats:italic>p<\/jats:italic>\n                      -value\u2009&lt;\u20090.05 at 95% confidence interval in multivariable logistic regression were considered statistically significant.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec004\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Among 2548 pulmonary tuberculosis (PTB)-suspected participants, the overall prevalence of\n                      <jats:italic>M. tuberculosis<\/jats:italic>\n                      (MTB) was 150\/2548 (5.9%). Rifampicin resistance was detected in 19\/150 (12.7%) of MTB-positive cases, urban residents 7\/70 (18.6%), and low education (grades 1\u22124), 3\/15 (20.0%). In multivariable logistic regression analysis, rural residence was associated with reduced PTB infection compared with urban residence (AOR: 0.23; 95% CI: 0.06\u20130.79;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.020). Previous antibiotic use (AOR: 9.17; 95% CI: 2.01\u201328.14;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.001), HIV-positivity (AOR: 3.73; 95% CI: 2.40\u20137.78;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.001) and alcohol consumption (AOR: 7.10; 95% CI: 4.99\u201320.86;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.001) were independently associated with increased MTB infection. Rural residents showed significantly lower odds of rifampicin-resistant MTB compared to urban counterparts (AOR: 0.35, 95% CI: 0.12\u20130.99,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.048).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec005\">\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>\n                      The prevalence of\n                      <jats:italic>M. tuberculosis<\/jats:italic>\n                      infection and rifampicin resistance remains significant in the study area. The strong association between prior antibiotic use, HIV-positivity and alcohol consumption with\n                      <jats:italic>M. tuberculosis<\/jats:italic>\n                      highlights the need for targeted case-finding, improved diagnosis, rational antibiotic use, and focused health education interventions.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1371\/journal.pone.0351964","type":"journal-article","created":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T17:47:02Z","timestamp":1782496022000},"page":"e0351964","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":0,"title":["Rifampicin resistance and associated factors of Mycobacterium tuberculosis among pulmonary tuberculosis-suspected patients in the Amhara National Regional State Comprehensive Specialized Hospitals, Ethiopia"],"prefix":"10.1371","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3713-6783","authenticated-orcid":true,"given":"Tebelay","family":"Dilnessa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feleke","family":"Moges","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Belay","family":"Tessema","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Workagegnehu","family":"Hailu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baye","family":"Gelaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2026,6,26]]},"reference":[{"issue":"1","key":"pone.0351964.ref001","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1097\/JS9.0000000000003412","article-title":"Global, regional, and national burden of tuberculosis, 1990-2050: a systematic comparative analysis based on retrospective cross-sectional of GBD 2021 and WHO surveillance systems","volume":"112","author":"F Jiang","year":"2026","journal-title":"Int J Surg"},{"key":"pone.0351964.ref002","unstructured":"World Health Organization. Global tuberculosis report 2023. Geneva: World Health Organization. 2023. https:\/\/www.who.int\/teams\/global-programme-on-tuberculosis-and-lung-health\/tb-reports\/global-tuberculosis-report-2023\/"},{"issue":"1","key":"pone.0351964.ref003","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s40249-023-01107-x","article-title":"Global prevalence of drug-resistant tuberculosis: a systematic review and meta-analysis","volume":"12","author":"N Salari","year":"2023","journal-title":"Infect Dis Poverty"},{"key":"pone.0351964.ref004","unstructured":"FMoH. Ethiopia national TB program annual performance report. Ministry of Health, Ethiopia. 2022. https:\/\/www.scribd.com\/document\/842034042\/WHO-Ethiopia-Annual-Report-2022-3\/"},{"issue":"4","key":"pone.0351964.ref005","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0214235","article-title":"Risk factors for tuberculosis: A case-control study in Addis Ababa, Ethiopia","volume":"14","author":"E Shimeles","year":"2019","journal-title":"PLoS One"},{"issue":"6","key":"pone.0351964.ref006","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0253177","article-title":"Prevalence of active tuberculosis disease among healthcare workers and support staff in healthcare settings of the Amhara region, Ethiopia","volume":"16","author":"MB Shiferaw","year":"2021","journal-title":"PLoS One"},{"key":"pone.0351964.ref007","doi-asserted-by":"crossref","first-page":"1319845","DOI":"10.3389\/fmed.2024.1319845","article-title":"Molecular detection of rifampicin-resistant Mycobacterium tuberculosis by polymerase chain reaction in Ethiopia: a systematic review and meta-analysis","volume":"11","author":"MY Birhanu","year":"2024","journal-title":"Front Med (Lausanne)"},{"key":"pone.0351964.ref008","unstructured":"WHO. Automated real-time nucleic acid amplification technology for rapid and simultaneous detection of tuberculosis and rifampicin resistance: Xpert MTB\/RIF assay for the diagnosis of pulmonary and extrapulmonary TB in adults and children: policy update. Geneva: World Health Organization. 2013. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK258610\/"},{"issue":"11","key":"pone.0351964.ref009","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1056\/NEJMoa0907847","article-title":"Rapid molecular detection of tuberculosis and rifampin resistance","volume":"363","author":"CC Boehme","year":"2010","journal-title":"N Engl J Med"},{"key":"pone.0351964.ref010","doi-asserted-by":"crossref","first-page":"3523","DOI":"10.2147\/IDR.S363628","article-title":"Determinants of multidrug-resistant mycobacterium tuberculosis infection: a multicenter study from Southern Ethiopia","volume":"15","author":"A Badgeba","year":"2022","journal-title":"Infect Drug Resist"},{"issue":"1","key":"pone.0351964.ref011","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1186\/s12889-018-5371-3","article-title":"Risk factors for the occurrence of multidrug-resistant tuberculosis among patients undergoing multidrug-resistant tuberculosis treatment in East Shoa, Ethiopia","volume":"18","author":"F Desissa","year":"2018","journal-title":"BMC Public Health"},{"issue":"11","key":"pone.0351964.ref012","article-title":"Potential contribution of HIV during first-line tuberculosis treatment to subsequent rifampicin-monoresistant tuberculosis and acquired tuberculosis drug resistance in South Africa: a retrospective molecular epidemiology study","volume":"2","author":"H Cox","year":"2021","journal-title":"Lancet Microbe"},{"key":"pone.0351964.ref013","doi-asserted-by":"crossref","first-page":"100336","DOI":"10.1016\/j.jctube.2022.100336","article-title":"Prevalence, associated factors and rifampicin resistance pattern of pulmonary tuberculosis among HIV-positive patients attending antiretroviral treatment clinic at East Gojjam Zone, Ethiopia: an institution-based cross-sectional study","volume":"29","author":"M Toru","year":"2022","journal-title":"J Clin Tuberc Other Mycobact Dis"},{"issue":"1","key":"pone.0351964.ref014","doi-asserted-by":"crossref","DOI":"10.1093\/jacamr\/dlae206","article-title":"Prevalence and factors associated with TB among presumptive TB patients in war-affected areas of North Wollo, Ethiopia","volume":"7","author":"Z Asmare","year":"2025","journal-title":"JAC Antimicrob Resist"},{"issue":"9","key":"pone.0351964.ref015","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2023.e19554","article-title":"Prevalence of rifampicin resistant pulmonary tuberculosis using geneXpert assay in Ethiopia, a systematic review and meta-analysis","volume":"9","author":"M Demelash","year":"2023","journal-title":"Heliyon"},{"key":"pone.0351964.ref016","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s40794-018-0065-5","article-title":"Epidemiology of multidrug-resistant tuberculosis (MDR-TB) in Ethiopia: a systematic review and meta-analysis of the prevalence, determinants and treatment outcome","volume":"4","author":"T Girum","year":"2018","journal-title":"Trop Dis Travel Med Vaccines"},{"key":"pone.0351964.ref017","doi-asserted-by":"crossref","first-page":"1470234","DOI":"10.3389\/frhs.2024.1470234","article-title":"The availability and functionality of medical equipment and the barriers to their use at comprehensive specialized hospitals in the Amhara region, Ethiopia","volume":"4","author":"AE Woldeyohanins","year":"2025","journal-title":"Front Health Serv"},{"issue":"4","key":"pone.0351964.ref018","doi-asserted-by":"crossref","first-page":"117008","DOI":"10.1016\/j.diagmicrobio.2025.117008","article-title":"The clinical profile of patients with indeterminate Xpert rifampin resistance results in a single tertiary level institution","volume":"113","author":"BG Tenorio","year":"2025","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"1","key":"pone.0351964.ref019","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1186\/s13104-023-06394-z","article-title":"GeneXpert MTB\/RIF Ultra performance to detect uncommon rpoB mutations in Mycobacterium tuberculosis","volume":"16","author":"L Rigouts","year":"2023","journal-title":"BMC Res Notes"},{"key":"pone.0351964.ref020","unstructured":"WHO. Treatment of tuberculosis: guidelines. World Health Organization. 2009. http:\/\/whqlibdoc.who.int\/publications\/2010\/9789241547833_eng.pdf"},{"issue":"1","key":"pone.0351964.ref021","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1186\/s12879-020-4817-2","article-title":"Does Xpert\u00ae MTB\/RIF assay give rifampicin resistance results without identified mutation? Review of cases from Addis Ababa, Ethiopia","volume":"20","author":"A Alemu","year":"2020","journal-title":"BMC Infect Dis"},{"key":"pone.0351964.ref022","unstructured":"WHO. Xpert MTB\/RIF Implementation Manual: Technical and Operational \u2018How-To\u2019; Practical Considerations. Geneva: World Health Organization. 2014."},{"key":"pone.0351964.ref023","unstructured":"World Health Organization. WHO consolidated guidelines on tuberculosis: module 2: screening: systematic screening for tuberculosis disease. Geneva: World Health Organization. 2020. https:\/\/www.who.int\/publications\/i\/item\/9789240022676"},{"issue":"1","key":"pone.0351964.ref024","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s13104-016-2328-4","article-title":"Rifampicin-resistance pattern of Mycobacterium tuberculosis and associated factors among presumptive tuberculosis patients referred to Debre Markos Referral Hospital, Ethiopia: a cross-sectional study","volume":"10","author":"W Mulu","year":"2017","journal-title":"BMC Res Notes"},{"key":"pone.0351964.ref025","first-page":"293","article-title":"Tuberculosis and human immunodeficiency virus co-infection and associated factors at debre markos comprehensive specialized hospital, Northwest Ethiopia: a four-year retrospective study","volume":"13","author":"A Alemu","year":"2021","journal-title":"HIV AIDS (Auckl)"},{"issue":"1","key":"pone.0351964.ref026","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1054\/tuld.1998.0002","article-title":"Molecular genetic basis of antimicrobial agent resistance in Mycobacterium tuberculosis: 1998 update","volume":"79","author":"S Ramaswamy","year":"1998","journal-title":"Tuber Lung Dis"},{"key":"pone.0351964.ref027","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.2147\/IDR.S300585","article-title":"Magnitude of mycobacterium tuberculosis infection and its resistance to rifampicin using Xpert-MTB\/RIF assay among presumptive tuberculosis patients at motta general hospital, Northwest Ethiopia","volume":"14","author":"TA Demissie","year":"2021","journal-title":"Infect Drug Resist"},{"issue":"1","key":"pone.0351964.ref028","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1186\/s12879-024-09135-0","article-title":"Trends of Mycobacterium tuberculosis and Rifampicin resistance in Northwest Ethiopia: Xpert\u00ae MTB\/RIF assay results from 2015 to 2021","volume":"24","author":"S Biset","year":"2024","journal-title":"BMC Infect Dis"},{"issue":"1","key":"pone.0351964.ref029","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s40794-024-00224-1","article-title":"Trend of pulmonary tuberculosis and rifampicin-resistance among tuberculosis presumptive patients in Central Tigray, Ethiopia; 2018 -2023: a six-year retrospective study","volume":"10","author":"G Gebremariam","year":"2024","journal-title":"Trop Dis Travel Med Vaccines"},{"key":"pone.0351964.ref030","doi-asserted-by":"crossref","first-page":"1266780","DOI":"10.3389\/fmed.2023.1266780","article-title":"Pulmonary tuberculosis and multidrug-resistant Mycobacterium tuberculosis in northwestern Ethiopia: a hospital-based cross-sectional study among presumptive pulmonary tuberculosis patients","volume":"10","author":"B Wubu","year":"2023","journal-title":"Front Med (Lausanne)"},{"key":"pone.0351964.ref031","doi-asserted-by":"crossref","first-page":"20503121211045541","DOI":"10.1177\/20503121211045541","article-title":"Prevalence of Mycobacterium tuberculosis infection and rifampicin resistance among presumptive tuberculosis cases visiting tuberculosis clinic of Adare General Hospital, Southern Ethiopia","volume":"9","author":"DB Andarge","year":"2021","journal-title":"SAGE Open Med"},{"issue":"7","key":"pone.0351964.ref032","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2022-070594","article-title":"Prevalence and incidence of symptomatic pulmonary tuberculosis based on repeated population screening in a district in Ethiopia: a prospective cohort study","volume":"13","author":"AB Banti","year":"2023","journal-title":"BMJ Open"},{"issue":"6","key":"pone.0351964.ref033","doi-asserted-by":"crossref","first-page":"635","DOI":"10.5588\/ijtld.13.0417","article-title":"The first population-based national tuberculosis prevalence survey in Ethiopia, 2010-2011","volume":"18","author":"AH Kebede","year":"2014","journal-title":"Int J Tuberc Lung Dis"},{"issue":"1","key":"pone.0351964.ref034","doi-asserted-by":"crossref","first-page":"10455","DOI":"10.1038\/s41598-024-59435-3","article-title":"Population structure and spatial distribution of Mycobacterium tuberculosis in Ethiopia","volume":"14","author":"M Getahun","year":"2024","journal-title":"Sci Rep"},{"key":"pone.0351964.ref035","doi-asserted-by":"crossref","first-page":"997025","DOI":"10.3389\/fpubh.2022.997025","article-title":"Gender differences in tuberculosis incidence rates-A pooled analysis of data from seven high-income countries by age group and time period","volume":"10","author":"V Peer","year":"2023","journal-title":"Front Public Health"},{"issue":"3","key":"pone.0351964.ref036","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0280396","article-title":"Prevalence and factors associated with tuberculosis among the mining communities in Mererani, Tanzania","volume":"18","author":"AW Mbuya","year":"2023","journal-title":"PLoS One"},{"issue":"7","key":"pone.0351964.ref037","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0289137","article-title":"Intersections of informal work status, gender and tuberculosis diagnosis: Insights from a qualitative study from an Indian setting","volume":"18","author":"S George","year":"2023","journal-title":"PLoS One"},{"key":"pone.0351964.ref038","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/1471-2458-9-53","article-title":"Delayed consultation among pulmonary tuberculosis patients: a cross sectional study of 10 DOTS districts of Ethiopia","volume":"9","author":"MM Mesfin","year":"2009","journal-title":"BMC Public Health"},{"issue":"1","key":"pone.0351964.ref039","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1186\/s12889-020-8290-z","article-title":"High urban tuberculosis case notification rates can be misleading: evidence from an urban setting in Ethiopia","volume":"20","author":"D Datiko","year":"2020","journal-title":"BMC Public Health"},{"issue":"1","key":"pone.0351964.ref040","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1186\/s12890-023-02713-z","article-title":"Lower socioeconomic status associated with higher tuberculosis rate in South Korea","volume":"23","author":"S-W Choi","year":"2023","journal-title":"BMC Pulm Med"},{"issue":"1","key":"pone.0351964.ref041","first-page":"205074","article-title":"Prevalence and antimicrobial susceptibility pattern of bacteria isolated from mobile phones of health care professionals working in Gondar town health centers","volume":"2014","author":"M Gashaw","year":"2014","journal-title":"Int Sch Res Notices"},{"issue":"2","key":"pone.0351964.ref042","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0171800","article-title":"Spatial patterns of multidrug resistant tuberculosis and relationships to socio-economic, demographic and household factors in northwest Ethiopia","volume":"12","author":"KA Alene","year":"2017","journal-title":"PLoS One"},{"key":"pone.0351964.ref043","article-title":"Prevalence of Tuberculosis in Sub-Saharan Africa","author":"B Heaton","year":"2022","journal-title":"Ballard Brief"},{"issue":"1","key":"pone.0351964.ref044","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1186\/s40249-017-0380-5","article-title":"Effects of sociodemographic characteristics and patients\u2019 health beliefs on tuberculosis treatment adherence in Ethiopia: a structural equation modelling approach","volume":"6","author":"HH Tola","year":"2017","journal-title":"Infect Dis Poverty"},{"issue":"07","key":"pone.0351964.ref045","doi-asserted-by":"crossref","first-page":"110","DOI":"10.54393\/pjhs.v5i07.1764","article-title":"Prevalence and diagnosis of rifampicin-resistant mycobacterium tuberculosis using the GeneXpert MTB\/RIF assay at a tertiary care children\u2019s hospital","volume":"5","author":"R Jameel","year":"2024","journal-title":"PJHS"},{"issue":"1","key":"pone.0351964.ref046","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0262929","article-title":"Detection of Mycobacterium tuberculosis and rifampicin resistance by Xpert\u00ae MTB\/RIF assay among presumptive tuberculosis cases at Jimma University Medical Center, Southwest Ethiopia","volume":"17","author":"W Admassu","year":"2022","journal-title":"PloS One"},{"key":"pone.0351964.ref047","doi-asserted-by":"crossref","first-page":"3451","DOI":"10.2147\/IDR.S263023","article-title":"Rifampicin-Resistant Mycobacterium tuberculosis Among Patients with Presumptive Tuberculosis in Addis Ababa, Ethiopia","volume":"13","author":"S Araya","year":"2020","journal-title":"Infect Drug Resist"},{"issue":"3","key":"pone.0351964.ref048","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1007\/s40121-020-00368-5","article-title":"Prevalence of Mycobacterium tuberculosis (Rifampicin-resistant MTB) and associated risk actors among pulmonary presumptive TB patients in Eastern Amhara, Ethiopia: 2015-2019","volume":"10","author":"AG Wasihun","year":"2021","journal-title":"Infect Dis Ther"},{"issue":"4","key":"pone.0351964.ref049","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2015-009058","article-title":"Determinants for tuberculosis in HIV-infected adults in Northwest Ethiopia: a multicentre case-control study","volume":"6","author":"YM Alemu","year":"2016","journal-title":"BMJ Open"},{"issue":"9","key":"pone.0351964.ref050","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0239159","article-title":"Tuberculosis infection control practices and associated factors among healthcare workers in hospitals of Gamo Gofa Zone, Southern Ethiopia, institution-based cross-sectional study","volume":"15","author":"AW Tadesse","year":"2020","journal-title":"PLoS One"},{"issue":"2","key":"pone.0351964.ref051","doi-asserted-by":"crossref","first-page":"605","DOI":"10.4314\/ahs.v20i2.8","article-title":"Sex differences and HIV status of tuberculosis in adults at a rural hospital in southern Ethiopia: an 18-year retrospective cross-sectional study","volume":"20","author":"JM Ramos","year":"2020","journal-title":"Afr Health Sci"},{"key":"pone.0351964.ref052","first-page":"20499361241305517","article-title":"Stigma and associated sex disparities among patients with tuberculosis in Uganda: a cross-sectional study","volume":"11","author":"JN Sekandi","year":"2024","journal-title":"Ther Adv Infect Dis"},{"key":"pone.0351964.ref053","doi-asserted-by":"crossref","first-page":"45","DOI":"10.4103\/AMJM.AMJM_17_21","article-title":"Sociodemographic determinants of tuberculosis burden in India","volume":"17","author":"M Roy","year":"2021","journal-title":"Amrita J Med"},{"key":"pone.0351964.ref054","doi-asserted-by":"crossref","first-page":"1607892","DOI":"10.3389\/ijph.2025.1607892","article-title":"Incidence and risk factors of tuberculosis among children receiving antiretroviral therapy in Northwest, Ethiopia","volume":"70","author":"G Endalew","year":"2025","journal-title":"Int J Public Health"},{"key":"pone.0351964.ref055","article-title":"Prevalence, risk factors, and rifampicin resistance pattern of Mycobacterium tuberculosis in Sekota town, Northwest Ethiopia","volume":"32","author":"G Mengistu","year":"2025","journal-title":"Parasite Epidemiol Control"},{"key":"pone.0351964.ref056","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s40794-020-00115-1","article-title":"Trends of Mycobacterium tuberculosis and rifampicin resistance in Adigrat General Hospital, Eastern zone of Tigrai, North Ethiopia","volume":"6","author":"GK Abay","year":"2020","journal-title":"Trop Dis Travel Med Vaccines"},{"key":"pone.0351964.ref057","doi-asserted-by":"crossref","first-page":"20503121221086725","DOI":"10.1177\/20503121221086725","article-title":"Associated risk factor of tuberculosis infection among adult patients in Gedeo Zone, Southern Ethiopia","volume":"10","author":"K Diriba","year":"2022","journal-title":"SAGE Open Med"},{"key":"pone.0351964.ref058","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.2147\/IJGM.S278758","article-title":"Prevalence and associated factors of TB Co-Morbidity Among HIV Sero-Positive Individuals in Shegaw Motta District Hospital, Ethiopia","volume":"13","author":"A Fenta","year":"2020","journal-title":"Int J Gen Med"},{"issue":"2","key":"pone.0351964.ref059","first-page":"588","article-title":"Prevalence and associated factors of TB\/HIV co-infection among HIV Infected patients in Amhara region, Ethiopia","volume":"16","author":"AA Mitku","year":"2016","journal-title":"Afr Health Sci"},{"key":"pone.0351964.ref060","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1186\/1471-2458-8-289","article-title":"Alcohol use as a risk factor for tuberculosis - a systematic review","volume":"8","author":"K L\u00f6nnroth","year":"2008","journal-title":"BMC Public Health"}],"container-title":["PLOS One"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0351964","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T17:47:13Z","timestamp":1782496033000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0351964"}},"subtitle":[],"editor":[{"given":"Balew","family":"Arega Negatie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2026,6,26]]},"references-count":60,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2026,6,26]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0351964","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,26]]}}}